THE EFFECTS OF OBESITY ON FEMALE PATIENTS' REPRODUCTIVE FUNCTION IN IN VITRO FERTILIZATION (IVF) PROGRAMS
Main Article Content
Abstract
Due to the multifaceted impact of obesity on women's reproductive function, as well as the outcomes of assisted reproductive technology (ART) programs, there is an urgent need to study the impact of this disease and find ways to solve this problem in women with infertility planning ART programs.
This review reflects the literature data showing the mechanisms of the influence of obesity on the negative outcomes of ART programs. To achieve this goal, an electronic search was conducted for literature reviews, randomized clinical trials, and meta-analyses in the Medline, PubMed, Google Scholar, Clinical Trials, and the Cochrane databases until December 2024.
In the course of the work carried out, the mechanisms influencing the effectiveness of ART programs in obese patients were identified: adipose tissue is an inflammatory substrate, as a result of chronic inflammation it enhances the synthesis of reactive oxygen species. Reactive oxygen species reduce the quality of oocytes and, consequently, the quality of embryos. This pushes reproductive doctors to pay more attention to pre-pregnancy training of obese patients before ART programs.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Shevchenko EA, Potemina TE, Uspensky AN. Role of adiponektin and leptin in the development of metabolic syndrome and related obesity and type II diabetes mellitus. Bulletin of the Medical Institute «REAVIZ» (rehabilitation, doctor and health). 2022; (1): 29-37. Russian (Шевченко Е.А., Потемина Т.Е., Успенский А.Н. Роль адипонектина и лептина в развитии метаболического синдрома и связанных с ним ожирением и сахарным диабетом II типа //Вестник медицинского института «Реавиз»: реабилитация, врач и здоровье. 2022. № 1. С. 29-37.) doi: 10.20340/vmi-rvz.2022.1.CLIN.3
Pavlov Ayu, Dzidzaria AG, Kalinchenko SYu, Muravyova PV. A modern view on the problem: the impact of obesity as a key component of the metabolic syndrome on the development and progression of endometrial cancer. Malignant tumors. 2024; 14(2): 75-82. Russian (Павлов А.Ю., Дзидзария А.Г., Калинченко С.Ю., Муравьева П.В. Современный взгляд на проблему: влияние ожирения как ключевого компонента метаболического синдрома на развитие и прогрессирование рака эндометрия //Злокачественные опухоли. 2024. Т. 14, № 2. С. 75-82.) doi: 10.14341/omet13025
Chistyakova OV, Sukhov IB, Shpakov AO. Metabolic syndrome: relationship between oxidative stress and chronic inflammation. Russian Journal of Physiology named after I.M. Sechenov. 2018; 104(2): 138-155. Russian (Чистякова О.В., Сухов И.Б., Шпаков А.О. Метаболический синдром: причинно-следственные отношения между окислительным стрессом и хроническим воспалением //Российский физиологический журнал им. И.М. Сеченова. 2018. Т. 104, № 2. С. 138-155)
Shvarts VI. Inflammation of the adipose tissue (Part 4). Obesity: a new infectious disease? (a literature review). Problems of Endocrinology. 2011; 57(5): 63-71. Russian (Шварц В.Я. Воспаление жировой ткани (часть 4). Ожирение – новое инфекционное заболевание? (обзор литературы) //Проблемы эндокринологии. 2011. Т. 57, №. 5. С. 63-71.) doi: 10.14341/probl201157563-71
Yong W, Wang J, Leng Y, Li L, Wang H. Role of obesity in female reproduction. Int J Med Sci. 2023; 20(3): 366-375. doi: 10.7150/ijms.80189
Xie F, Anderson CL, Timme KR, Kurz SG, Fernando SC, Wood JR. Obesity-dependent increases in oocyte mRNAs are associated with increases in proinflammatory signaling and gut microbial abundance of Lachnospiraceae in female mice. Endocrinology. 2016; 157(4): 1630-1643. doi: 10.1210/en.2015-1851
Zhuk TV, Yavorskaya SD, Vostrikov VV. Predictors of IVF program failures in patients with infertility and excess body weight. Bulletin of Medical Science. 2017; 3(7): 58-59. Russian (Жук Т.В., Яворская С.Д., Востриков В.В. Предикторы неудач программ ЭКО у пациенток с бесплодием и профицитом массы тела //Бюллетень медицинской науки. 2017. № 3(7). С. 58-59)
Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil steril. 2017; 107(4): 840-847. doi: 10.1016/j.fertnstert.2017.01.017
Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, Fréour T. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum reprod update. 2019; 25(4): 439-451. doi: 10.1093/humupd/dmz011
Hunter E, Avenell A, Maheshwari A, Stadler G, Best D. The effectiveness of weight‐loss lifestyle interventions for improving fertility in women and men with overweight or obesity and infertility: a systematic review update of evidence from randomized controlled trials. Obes rev. 2021; 22(12): e13325. doi: 10.1111/obr.13325
Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Obesity and metabolism. 2017; 14(1): 3-8. Russian (Горбатенко Н.В., Беженарь В.Ф., Фишман М.Б. Влияние ожирения на развитие нарушения репродуктивной функции у женщин //Ожирение и метаболизм. 2017. Т. 14, № 1. С. 3-8.) doi: 10.14341/omet201713-8
Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019; 158(3): R79-R90. doi: 10.1530/REP-18-0583
Volkova NI, Degtyareva YuS. Mechanisms of fertility disorders in obese women. Medical Bulletin of the South of Russia. 2020; 11(3): 15-19. Russian (Волкова Н.И., Дегтярева Ю.С. Механизмы нарушения фертильности у женщин с ожирением //Медицинский вестник Юга России. 2020. Т. 11, №. 3. С. 15-19.) doi: 10.21886/2219-8075-2020-11-3-15-19
Abdusalamova AI, Bettikher OA, Rudenko KA, Belyaeva OA, Neimark AE, Zazerskaya IE. Adipokinesand Ghrelin Rolein Regulation of Ovarian Function in Obesity. Obesity and metabolism. 2022; 19(3): 324-331. Russian (Абдусаламова А.И., Беттихер О.А., Руденко К.А., Беляева О.А., Неймарк А.Е., Зазерская И.Е. Роль адипокинов и грелина в регуляции овариальной функции при ожирении //Ожирение и метаболизм. 2022. Т. 19, № 3. С. 324-331.) doi: 10.14341/omet12825
Samoylova YuG, Matveeva MV, Petrov IA, Mitselya EV, Kudlay DA, Gaifulina ZhF. Oxidative stress and fertility. Nature, diagnosis and therapy Gynecology, Obstetrics and Perinatology. 2021; 20(4): 131-141. Russian (Самойлова Ю.Г., Матвеева М.В., Петров И.А., Мицеля Е.В., Кудлай Д.А., Гайфулина Ж.Ф. Оксидативный стресс и фертильность. Природа, диагностика, терапия //Вопросы гинекологии, акушерства и перинатологии. 2021. Т. 20, № 4. С. 131-141.) doi: 10.20953/1726-1678-2021-4-131-139
Leary C, Leese HJ, Sturmey RG. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. Hum reprod. 2015; 30(1): 122-132. doi: 10.1093/humrep/deu276
Ilovaiskaya IA. The effect of obesity in women on fertility and gestation. Russkij medicinskij zhurnal. 2016; 1: 32-7. Russian (Иловайская И.А. Влияние ожирения у женщин на фертильность и вынашивание беременности //РМЖ. 2016. № 1. С. 32-37.) doi: 10.33667/2078-5631-2020-4-27-32
Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil steril. 2017; 107(4): 840-847. doi: 10.1016/j.fertnstert.2017.01.017
Richani D, Dunning KR, Thompson JG, Gilchrist RB. Metabolic co-dependence of the oocyte and cumulus cells: essential role in determining oocyte developmental competence. Hum reprod update. 2021; 27(1): 27-47. doi: 10.1093/humupd/dmaa043
Saravanan P. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020; 8(9): 793-800. doi: 10.1016/S2213-8587(20)30161-3
Druzhinina AS, Vitiazeva II, Dimitrova DA. Correlation of in vitro fertilization (IVF) infertility treatment outcomes and body weight index in women of reproductive age. Problems of Endocrinology. 2021; 67(1): 76-82. Russian (Дружинина А.С., Витязева И.И., Димитрова Д.А. Корреляция исходов лечения бесплодия методом экстракорпорального оплодотворения (ЭКО) и массы тела женщин репродуктивного возраста //Проблемы эндокринологии. 2021. Т. 67, №. 1. С. 76-82.) doi: 10.14341/probl12727